DavidFranklinFiorentinoMDPhD

Dermatology • Stanford, CA

Associate Professor, Dermatology, Stanford University Medical Center

Join to view full profile

Dr. Fiorentino is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Fiorentino's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Fax+1 650-723-7796

Education & Training

Stanford Health Care-Sponsored Stanford UniversityResidency, Dermatology, 1999 - 2002
University of ColoradoInternship, Internal Medicine, 1998 - 1999
Stanford University School of MedicineClass of 1998

Certifications & Licensure

CA State Medical License 1999 - 2026
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus Start of enrollment: 2006 Aug 01
Terminated
Phase 2
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease Start of enrollment: 2006 Aug 01
Completed
Not Applicable
A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma) Start of enrollment: 2008 Nov 01
Completed
Phase 1, Phase 2
A Study to Evaluate the Safety and Effectiveness of Etanercept in Treating Lichen Planus on the Oral Mucosa or Skin Start of enrollment: 2006 Jan 01
Safety and Efficacy Study of Humira in Treatment of Pyoderma Gangrenosum Start of enrollment: 2009 May 01
Withdrawn
Phase 2
A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis Start of enrollment: 2010 Feb 01
Terminated
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Lipodermatosclerosis and Pulmonary Hypertension in Systemic Sclerosis.
Srijana Davuluri, Puneet Kapoor, Swarna Nandyala, Shufeng Li, Julia Simard
JAMA Dermatology. 2024-12-01
Editorial myositis and myopathies.
David Fiorentino, Livia Casciola-Rosen
Current Opinion in Rheumatology. 2024-11-01
Clinical Characteristics of Anti-synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project.
Sara Faghihi-Kashani, Akira Yoshida, Francisca Bozan, Giovanni Zanframundo, Davide Rozza
Arthritis & Rheumatology. 2024-10-28

Journal Articles

Clinical Significance of Autoantibodies in Dermatomyositis and Systemic Sclerosis
David F Fiorentino, Lorinda Chung, ScienceDirect

Press Mentions

Autoantibodies Signal Reduced Cancer Risk in DermatomyositisFebruary 17th, 2023
FDA Approves New Drug, Sotyktu, for Treatment of Plaque PsoriasisSeptember 10th, 2022
Reviewers' List December 2020August 12th, 2020
Join now to see all

Professional Memberships

American College of Rheumatology - ACR
Member
American Academy of Dermatology - AAD
Fellow
American College of Radiology - ACR
Clinical Member